Deubiquitinating enzyme OTUB1 in immunity and cancer: Good player or bad actor?

Yihao Liao1, Mengyue Yang2, Keke Wang1

  • 1Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.

Cancer Letters
|December 7, 2021
PubMed

Insights

OTU deubiquitinase domain-containing protein 1 (OTUB1) is crucial in DNA repair and immune responses. Targeting OTUB1 shows potential for treating cancers and immune disorders by modulating immune cell activity.

Area of Science:

  • Biochemistry
  • Immunology
  • Oncology

Background:

  • OTU deubiquitinase domain-containing protein 1 (OTUB1) is a key member of the deubiquitinase OTU superfamily.
  • OTUB1 regulates critical physiological processes including DNA damage repair and cytokine secretion.
  • Emerging research highlights OTUB1's role in cancer development and its intricate connection with the immune system.

Purpose of the Study:

  • To provide a comprehensive overview of OTUB1's function and regulatory mechanisms.
  • To explore the implications of OTUB1 in immune responses and cancer progression.
  • To evaluate OTUB1 as a potential therapeutic target for cancer and immune-related diseases.

Main Methods:

  • Literature review of experimental evidence on OTUB1.
  • Analysis of OTUB1's deubiquitinating and protein-stabilizing activities.
  • Examination of OTUB1's impact on immune cell function and cancer pathways.

Main Results:

  • OTUB1 influences NK/CD8 T cell activation, autoimmune diseases, and immune evasion via PD-L1.
  • OTUB1 plays a role in immune responses to viral/bacterial infections and cancer development.
  • Deubiquitinating and stabilizing target proteins are key mechanisms for OTUB1's action.

Conclusions:

  • Regulating OTUB1 levels can balance immune response and defense mechanisms.
  • Targeting OTUB1 presents a promising strategy to inhibit cancer progression.
  • OTUB1 is identified as a feasible therapeutic target for various cancers and immune disorders.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K